Faeth Therapeutics, Inc.

Public

Austin, TexasBiotechhttps://www.faeththerapeutics.com/

Faeth Therapeutics, Inc. is now publicly traded

The data on this page reflects Faeth Therapeutics, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

M&A

Feb 17, 2026

Est. Valuation at Exit

$368.32M

Total Funding Raised

$292M

Company Overview

Faeth Therapeutics, Inc. is a clinical-stage biotechnology company that develops precision therapies and nutritional interventions for cancer treatment.

Sector

Biotech

Verticals

Life Sciences, Oncology

AI Layer

Infrastructure

Keywords

precision oncologymetabolic therapycancer metabolismnutrient controldrug discoveryMetabOScomputational biologysolid tumor therapymetabolic interventioncancer researchbiotechmetabolic medicinenutritional oncologyclinical trialscancer starvation

Faeth Therapeutics, Inc. Comparables

Compare Faeth Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Faeth Therapeutics, Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Filtricine	73%
ImmunoMet Therapeutics	67%
Celcuity Inc.	67%

View all Comparables

Faeth Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Feb 17, 2026
VC Round	Oct 20, 2025
Series A	Jun 30, 2022
Seed	Jan 18, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Anand Parikh

Chief Executive Officer & Founder

Founding Team

Brian Stephenson

CFO at Faeth Therapeutics

Executive Team

Faeth Therapeutics, Inc. Investors

Notable investors and investment history

Faeth Therapeutics, Inc. investors
Investor	Rounds
Balyasny Asset Management L.P.	M&A
RA Capital Management	M&A
Future Ventures	Series A, VC Round, Seed
Columbia Threadneedle Investments	M&A
Fairmount Funds Management	M&A
Digitalis Ventures	Series A, VC Round, Seed
B Capital Group	VC Round

View all Investors

Faeth Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Faeth Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersAustin, Texas

Employee Range37

Year Founded2019

Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?